Joon Lee
Stock Analyst at Truist Securities
(4.74)
# 155
Out of 4,996 analysts
113
Total ratings
59.46%
Success rate
42.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAPP Rapport Therapeutics | Initiates: Buy | $44 | $26.59 | +65.48% | 1 | Sep 16, 2025 | |
| ARGX argenx SE | Maintains: Buy | $700 → $918 | $712.03 | +28.93% | 13 | Sep 15, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $520 → $490 | $385.74 | +27.03% | 4 | Aug 5, 2025 | |
| PTCT PTC Therapeutics | Maintains: Buy | $80 → $86 | $58.99 | +45.79% | 2 | Jul 29, 2025 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $95 → $75 | $25.57 | +193.31% | 8 | Apr 28, 2025 | |
| ARVN Arvinas | Maintains: Buy | $65 → $21 | $8.27 | +153.93% | 6 | Apr 9, 2025 | |
| CORT Corcept Therapeutics | Maintains: Buy | $76 → $150 | $83.87 | +78.85% | 8 | Mar 31, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $90 → $50 | $16.31 | +206.56% | 4 | Mar 4, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $175 → $85 | $52.02 | +63.40% | 5 | Mar 3, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $190 → $200 | $116.76 | +71.29% | 5 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $120 | $61.67 | +94.58% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $5.10 | +253.29% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $44 → $57 | $106.69 | -46.57% | 6 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $6.15 | +160.16% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $36 | $6.80 | +429.41% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $19.52 | +84.43% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $3.24 | +146.91% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $11.30 | +50.44% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $118 → $90 | $53.85 | +67.13% | 2 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $4.51 | +786.92% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $127.00 | +57.48% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $3.25 | +53.85% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $4.52 | +298.23% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $2.42 | +11,470.25% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $23.58 | +44.19% | 1 | Mar 16, 2021 |
Rapport Therapeutics
Sep 16, 2025
Initiates: Buy
Price Target: $44
Current: $26.59
Upside: +65.48%
argenx SE
Sep 15, 2025
Maintains: Buy
Price Target: $700 → $918
Current: $712.03
Upside: +28.93%
Vertex Pharmaceuticals
Aug 5, 2025
Maintains: Buy
Price Target: $520 → $490
Current: $385.74
Upside: +27.03%
PTC Therapeutics
Jul 29, 2025
Maintains: Buy
Price Target: $80 → $86
Current: $58.99
Upside: +45.79%
Viking Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $95 → $75
Current: $25.57
Upside: +193.31%
Arvinas
Apr 9, 2025
Maintains: Buy
Price Target: $65 → $21
Current: $8.27
Upside: +153.93%
Corcept Therapeutics
Mar 31, 2025
Maintains: Buy
Price Target: $76 → $150
Current: $83.87
Upside: +78.85%
Intellia Therapeutics
Mar 4, 2025
Maintains: Buy
Price Target: $90 → $50
Current: $16.31
Upside: +206.56%
Praxis Precision Medicines
Mar 3, 2025
Maintains: Buy
Price Target: $175 → $85
Current: $52.02
Upside: +63.40%
Axsome Therapeutics
Feb 19, 2025
Maintains: Buy
Price Target: $190 → $200
Current: $116.76
Upside: +71.29%
Feb 12, 2025
Maintains: Buy
Price Target: $100 → $120
Current: $61.67
Upside: +94.58%
Jan 29, 2025
Initiates: Buy
Price Target: $18
Current: $5.10
Upside: +253.29%
Jan 8, 2025
Reiterates: Buy
Price Target: $44 → $57
Current: $106.69
Upside: -46.57%
Jan 8, 2025
Initiates: Buy
Price Target: $16
Current: $6.15
Upside: +160.16%
Nov 12, 2024
Maintains: Buy
Price Target: $17 → $36
Current: $6.80
Upside: +429.41%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $19.52
Upside: +84.43%
Nov 5, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $3.24
Upside: +146.91%
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $11.30
Upside: +50.44%
Sep 17, 2024
Maintains: Buy
Price Target: $118 → $90
Current: $53.85
Upside: +67.13%
Aug 14, 2024
Maintains: Buy
Price Target: $60 → $40
Current: $4.51
Upside: +786.92%
Mar 20, 2024
Reiterates: Buy
Price Target: $200
Current: $127.00
Upside: +57.48%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $3.25
Upside: +53.85%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $4.52
Upside: +298.23%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $2.42
Upside: +11,470.25%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $23.58
Upside: +44.19%